Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
5-fluorouracil administered as a 48-hour semiintermittent infusion in combination with leucovorin, cisplatin and epirubicin: phase II study in advanced gastric cancer patients.
Allegrini G, Falcone A, Di Marsico R, Lencioni M, Masi G, Galli C, Cupini S, Pfanner E, Marcucci L, Conte PF. Allegrini G, et al. Among authors: galli c. Am J Clin Oncol. 2004 Feb;27(1):101-5. doi: 10.1097/01.coc.0000047128.73574.e6. Am J Clin Oncol. 2004. PMID: 14758142 Clinical Trial.
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study.
Falcone A, Allegrini G, Lencioni M, Pfanner E, Brunetti I, Cianci C, Galli C, Masi G, Antonuzzo A, Conte P. Falcone A, et al. Among authors: galli c. Cancer Chemother Pharmacol. 1999;44(2):159-63. doi: 10.1007/s002800050961. Cancer Chemother Pharmacol. 1999. PMID: 10412951 Clinical Trial.
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
Di Costanzo F, Sobrero A, Gasperoni S, Dogliotti L, Frassineti L, Falcone A, Lionetto R, Bruzzi P, Luppi G, Gallo L, Conte P, Comandone A, Turci D, Marzola M, Folco U, Pfanner E, Mestriner M, Boni C, Galli C, Tonato M, Rosso R; Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). Di Costanzo F, et al. Among authors: galli c. Ann Oncol. 2003 Sep;14(9):1365-72. doi: 10.1093/annonc/mdg359. Ann Oncol. 2003. PMID: 12954574 Free article. Clinical Trial.
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.
Fontana A, Galli L, Fioravanti A, Orlandi P, Galli C, Landi L, Bursi S, Allegrini G, Fontana E, Di Marsico R, Antonuzzo A, D'Arcangelo M, Danesi R, Del Tacca M, Falcone A, Bocci G. Fontana A, et al. Among authors: galli l, galli c. Clin Cancer Res. 2009 Aug 1;15(15):4954-62. doi: 10.1158/1078-0432.CCR-08-3317. Epub 2009 Jul 21. Clin Cancer Res. 2009. PMID: 19622584 Clinical Trial.
Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer.
Galli L, Fontana A, Galli C, Landi L, Fontana E, Antonuzzo A, Andreuccetti M, Aitini E, Barbieri R, Di Marsico R, Falcone A. Galli L, et al. Among authors: galli c. Br J Cancer. 2007 Dec 17;97(12):1613-7. doi: 10.1038/sj.bjc.6604090. Epub 2007 Nov 20. Br J Cancer. 2007. PMID: 18026196 Free PMC article. Clinical Trial.
Hypersensitivity reactions related to oxaliplatin (OHP).
Brandi G, Pantaleo MA, Galli C, Falcone A, Antonuzzo A, Mordenti P, Di Marco MC, Biasco G. Brandi G, et al. Among authors: galli c. Br J Cancer. 2003 Aug 4;89(3):477-81. doi: 10.1038/sj.bjc.6601155. Br J Cancer. 2003. PMID: 12888815 Free PMC article. Clinical Trial.
Temozolomide as first-line agent in treating high-grade gliomas: phase II study.
Chibbaro S, Benvenuti L, Caprio A, Carnesecchi S, Pulerà F, Faggionato F, Serino D, Galli C, Andreuccetti M, Buxton N, Gagliardi R. Chibbaro S, et al. Among authors: galli c. J Neurooncol. 2004 Mar-Apr;67(1-2):77-81. doi: 10.1023/b:neon.0000021728.36747.93. J Neurooncol. 2004. PMID: 15072451 Clinical Trial.
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022-2023.
Pellegrinelli L, Giardina FAM, Novazzi F, Vian E, Biscaro V, Russo C, Ranno S, Renteria SU, Callegaro A, Pagani E, Masi E, Tiberio C, Esposito M, Marinelli K, Menzo S, Binda S, Rovida F, Mancini N, Colacicco AM, Scarasciulli M, Lalle E, Maggi F, Piccirilli G, Lazzarotto T, Piralla A, Baldanti F, Pariani E; AMCLI GLIViRe Working group. Pellegrinelli L, et al. Virology. 2024 Dec 16;603:110302. doi: 10.1016/j.virol.2024.110302. Online ahead of print. Virology. 2024. PMID: 39689418 No abstract available.
1,129 results